checkAd

Holmusk continues ambitious US growth with NYC headquarters and expanded management team

Nachrichtenquelle: PR Newswire (engl.)
20.04.2021, 08:00  |  127   |   |   

NEW YORK, April 20, 2021 /PRNewswire/ -- Holmusk, a leading global data science and digital health company building the largest Real-World Evidence (RWE) platform for behavioral health, announced today the opening of its headquarters in New York City and addition of three new members to its management team to drive the company's ambitious growth plans.

New hires include Tony Tramontin, PhD (Chief of Strategic Partnerships), Scott H. Kollins, PhD (Chief Medical Officer), and Holly J. Logue (General Counsel). This expansion strengthens Holmusk's position as a global leader, with strong partnerships and presence in Asia-Pacific, North America, and Europe.

"Formally establishing a base in New York City solidifies our strategic growth plans in the US and elevates our ability to engage deeply with our partners here," said Nawal Roy, founder and CEO of Holmusk. "While we have always been a global-first company, we know healthcare challenges need to be solved at the local and regional level. Our New York office is strategically located in the Northeast Biotech corridor, with superb access to our pharma partners, regulatory bodies, policy organizations, and investors."

Bringing together a range of exceptional industry and scientific experience, the new executive leaders will play a critical role in driving the company's traction and growth:

  • Tony Tramontin, PhD, Chief of Strategic Partnerships, drives new long-term strategic engagements with partners across the healthcare ecosystem, including pharma, health systems, and payers. Tony was previously Chief Scientific Officer at Axcella Health and a partner in the Life Sciences & Healthcare Practice of McKinsey & Company.
  • Scott H. Kollins, PhD, Chief Medical Officer, leads the company's collaborations with academic, clinical, and regulatory stakeholders, with a focus on building Holmusk's platform at the intersection of technology, data science, and healthcare. Scott developed expertise in clinical research and digital health as a faculty member at Duke University School of Medicine. He also served as the Global Lead for ADHD and Substance Use Disorders, and Co-Lead for the Digital Health Solutions Initiative at the Duke Clinical Research Institute.
  • Holly J. Logue, General Counsel, oversees all legal and policy activities related to corporate governance. Holly brings wide-ranging expertise relevant to life sciences and machine learning technology, as well as in legal aspects of growing innovative businesses, from intellectual property to global compliance. She previously was Head of Strategic Assets and General Counsel at Drawbridge Health, a medical device and diagnostic company.

Michael Weintraub, Holmusk Board Chair, commented: "I am thrilled to welcome these new leaders, with their extensive capabilities and broad expertise across healthcare and life sciences. Holmusk's unique platform has the potential to powerfully change behavioral health, and these strategic additions to the leadership team will enable the company achieve this ambitious vision."

Seite 1 von 2
Blei jetzt über den Testsieger (Finanztest 11/2020) handeln, ab 0 € auf Smartbroker.de



Wertpapier



0 Kommentare

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

Holmusk continues ambitious US growth with NYC headquarters and expanded management team NEW YORK, April 20, 2021 /PRNewswire/ - Holmusk, a leading global data science and digital health company building the largest Real-World Evidence (RWE) platform for behavioral health, announced today the opening of its headquarters in New York City …

Community

Nachrichten des Autors

Titel
Titel
Titel
Titel